Caricamento...
Bedaquiline inhibits the yeast and human mitochondrial ATP synthases
Bedaquiline (BDQ, Sirturo) has been approved to treat multidrug resistant forms of Mycobacterium tuberculosis. Prior studies suggested that BDQ was a selective inhibitor of the ATP synthase from M. tuberculosis. However, Sirturo treatment leads to an increased risk of cardiac arrhythmias and death,...
Salvato in:
| Pubblicato in: | Commun Biol |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group UK
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7438494/ https://ncbi.nlm.nih.gov/pubmed/32814813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-020-01173-z |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|